Cargando…
Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer’s disease progression
We conducted a randomized placebo-controlled double-blind 24-week trial using Melissa officinalis (M. officinalis) extract richly containing rosmarinic acid (RA) on patients with mild dementia due to Alzheimer’s disease (AD) with the aim to examine the safety and tolerability (primary endpoint) of R...
Autores principales: | Noguchi-Shinohara, Moeko, Ono, Kenjiro, Hamaguchi, Tsuyoshi, Nagai, Toshitada, Kobayashi, Shoko, Komatsu, Junji, Samuraki-Yokohama, Miharu, Iwasa, Kazuo, Yokoyama, Kunihiko, Nakamura, Hiroyuki, Yamada, Masahito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596544/ https://www.ncbi.nlm.nih.gov/pubmed/33122694 http://dx.doi.org/10.1038/s41598-020-73729-2 |
Ejemplares similares
-
Pharmacokinetics, Safety and Tolerability of Melissa officinalis Extract which Contained Rosmarinic Acid in Healthy Individuals: A Randomized Controlled Trial
por: Noguchi-Shinohara, Moeko, et al.
Publicado: (2015) -
Spontaneous MEG activity of the cerebral cortex during eyes closed and open discriminates Alzheimer’s disease from cognitively normal older adults
por: Ikeda, Yoshihisa, et al.
Publicado: (2020) -
A new computerized assessment battery for cognition (C-ABC) to detect mild cognitive impairment and dementia around 5 min
por: Noguchi-Shinohara, Moeko, et al.
Publicado: (2020) -
Rosmarinic Acid and Melissa officinalis Extracts Differently Affect Glioblastoma Cells
por: Ramanauskiene, Kristina, et al.
Publicado: (2016) -
Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway
por: Yamamoto, So, et al.
Publicado: (2021)